GOLDLINE PHARMACEUTICAL LIMITE

GLPL

pharmaceuticals
₹56.77
+13.77 (+32.02%)

Stock price as on 19 May 2026 at 10:14 AM

Goldline pharmaceutical limite share price update

As of the latest trading session, Goldline Pharmaceutical Limite share price is currently at ₹56.77, which is up by ₹13.77 from its previous closing. ...

Goldline Pharmaceutical Limite stock performance

Today’s low

₹56.77

Today’s high

₹60

₹56.77

52 week low

₹0

52 week high

₹0

₹56.77
Open
₹59.75
Previous close
₹43.00
Share volume
0
Total traded value (Lakh)
₹0.00
Upper circuit
₹62.73
Lower circuit
₹56.77

Goldline Pharmaceutical Limite fundamentals

Market cap (Cr)
₹0.00
P/E ratio (TTM)
0
Book value per share
₹0.00
Beta
0
Return on equity
0%
Earnings per share (TTM)
₹0.00
Dividend yield
0%
Net profit/quarter (Cr)
₹0.00

Goldline Pharmaceutical Limite technical summary

₹0
0 ▼
0
Bearish
0
Bullish
5 Day0
10 Day0
12 Day0
20 Day0
26 Day0
50 Day0
100 Day0
200 Day0
5 Day0
10 Day0
12 Day0
20 Day0
26 Day0
50 Day0
100 Day0
200 Day0
First support
₹0.00
First resistance
₹0.00
Second support
₹0.00
Second resistance
₹0.00
Third support
₹0.00
Third resistance
₹0.00
RSI
0
ADX
0
MACD
0
Williams % R
0
Commodity Channel Index (CCI)
0
Same day
0
Week
0
Month
0
1 year
0
3 years
0
Over 1 month
0%
Over 1 year
0%
Over 3 months
0%
Over 3 years
0%
Over 6 months
0%
Over 6 years
0%

Investment Returns

Over 1 Month0%
Over 3 Months0%
Over 6 Months0%
Over 1 Year0%

Goldline Pharmaceutical Limite Shareholding pattern


Public
20.29%
Promoter holdings
79.7%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Swapan Premprakash Khandelwal

27,49,988 (39.85%)

Shareholding of Promoter and Promoter Group

Amol Laxmikant Mujumdar

27,49,988 (39.85%)

Shareholding of Promoter and Promoter Group

Aishwarya Amol Mujumdar

3 (0%)

Shareholding of Promoter and Promoter Group

Asha Swapan Khandelwal

3 (0%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Swapan Premprakash Khandelwal27,49,988 (39.85%)Shareholding of Promoter and Promoter Group
Amol Laxmikant Mujumdar27,49,988 (39.85%)Shareholding of Promoter and Promoter Group
Aishwarya Amol Mujumdar3 (0%)Shareholding of Promoter and Promoter Group
Asha Swapan Khandelwal3 (0%)Shareholding of Promoter and Promoter Group

About GOLDLINE PHARMACEUTICAL LIMITE

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f. September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma, Goldline Car

Parent Organisation

Indian Private

NSE Symbol

GOLDLINE PHARMACEUTICAL LIMITE

Founded

2004

GOLDLINE PHARMACEUTICAL LIMITE CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

KETOMOTORS

KETO MOTORS LIMITED

110.23
+100.23 (+1002.3%)
GLPL

GOLDLINE PHARMACEUTICAL LIMITE

56.77
+13.77 (+32.02%)
VRFILMS

V R FILMS & STUDIOS LIMITED

14.88
+2.48 (+20%)
BNALTD

B & A LTD.

421
+68.5 (+19.43%)
View all

Top gainers

TECHM

TECH MAHINDRA LIMITED

1497.9
+67.90 (+4.75%)
INFY

INFOSYS LIMITED

1189.7
+47.20 (+4.13%)
TCS

TATA CONSULTANCY SERV LT

2352.9
+69.70 (+3.05%)
TMPV

TATA MOTORS PASS VEH LTD

363
+9.85 (+2.79%)
View all

Top losers

COALINDIA

COAL INDIA LTD

456.6
-5.50 (-1.19%)
BHARTIARTL

BHARTI AIRTEL LIMITED

1921
-17.10 (-0.88%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

388.65
-3.15 (-0.80%)
ICICIBANK

ICICI BANK LTD.

1241.1
-10.00 (-0.80%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)